Earticle

현재 위치 Home

Symposium :Co-organized by Asian Federation of Biotechnology : Chairs: Duk Jae OH(Sejong University, Korea), Virendra S. BISARIA(Indian Institute of Technology Delhi, India)

The Status of Bioindustry in Incheon and Its Growth Strategies

첫 페이지 보기
  • 발행기관
    한국생물공학회 바로가기
  • 간행물
    한국생물공학회 학술대회 바로가기
  • 통권
    2010 추계학술대회 및 국제심포지움 (2010.10)바로가기
  • 페이지
    pp.87-87
  • 저자
    Beom-Seop Rho
  • 언어
    한국어(KOR)
  • URL
    https://www.earticle.net/Article/A129142

※ 원문제공기관과의 협약기간이 종료되어 열람이 제한될 수 있습니다.

원문정보

초록

영어
Incheon is in an advantageous position of fostering biomedical industries than other areas in Korea as it has many supporting infrastructures such as Korea Biotechnology Commercialization Center, Korea Conformity Laboratories, university clinical centers and research institutes. International airport and an international seaport located in this area is another strength for global business and international trade. Incheon also has some prominent biotechnology companies including Celltrion, Bernabiotech Korea and TS company, etc. Incheon City Government started its plans to nurture a bioindustry in 2004 and has supported to make favorable business environment since then. It has been constructing the Incheon Bioindustry Support Center and Songdo Science Village to provide core R&D facilities, housing and amenities. Incheon Free Economic Zone Authority(IFEZA) has been establishing biomedical clusters in Songdo, Cheongna and Yeongjong area. Its main businesses are to develop the Bio-Medi Park, BIT Port and Midi City. IFEZA decided to develop Songdo area as a high technology industrial complex and has been inducing renowned companies and research institutes from all over the world. Yonsei University Global Academic Complex, Bio Research Complex and Songdo Global Campus, etc. are constructed in this area. As of now, the number of biotechnology companies in Incheon is less than twenty. However, bioindustry in Incheon will encounter rapid growth within a few years, in its size, number, and quality of infrastructures.
IFEZA has been working to attract diverse investments and contracts from foreign companies, universities and hospitals. In less than a decade, Incheon is expected to rise as a hub of biomedical industries in the Northeast Asia.

저자

  • Beom-Seop Rho [ Biotechnology Department, Songdo Technopark, Incheon 406-840, Korea. ]

참고문헌

자료제공 : 네이버학술정보

간행물 정보

발행기관

  • 발행기관명
    한국생물공학회 [The Korean Society for Biotechnology and Bioengineering]
  • 설립연도
    1984
  • 분야
    공학>생물공학
  • 소개
    이 법인은 생물 공학의 발전과 보급에 이바지하고, 회원 상호 간의 연구 협력과 친목을 도모함을 목적으로 한다 1. 생물공학 분야의 발전을 위한 연구 협력 2. 생물공학의 실용화를 촉진시키기 위한 산학 협동 3. 학술연구 발표회, 강연회, 연수회 등 학술활동의 개최 4. 국,영문 학술지,소식지,학술회의 Proceedings 및 학술도서의 발간 5. 생물공학 발전을 위한 정책 건의 6. 기타 국제 교류 등 본 학회의 목적 달성을 위한 제반 활동

간행물

  • 간행물명
    한국생물공학회 학술대회
  • 간기
    반년간
  • 수록기간
    1985~2013
  • 십진분류
    KDC 476 DDC 576

이 권호 내 다른 논문 / 한국생물공학회 학술대회 2010 추계학술대회 및 국제심포지움

    피인용수 : 0(자료제공 : 네이버학술정보)

    함께 이용한 논문 이 논문을 다운로드한 분들이 이용한 다른 논문입니다.

      페이지 저장